Home › Companies › CRISPR THERAPEUTICS AG › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CRISPR THERAPEUTICS AG’s Form 8-K, filed June 4, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 4, 2026: 25 items on CRISPR THERAPEUTICS AG’s Form 8-K, filed June 4, 2026: 15 elected · 8 approved · 2 passed (calculated).
Significant dissent: 2 directors (27.1%, 27.1% against); 1 say-on-pay vote (69.4% support).
Notable dissent: 1 other board item (40.2% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore CRISPR THERAPEUTICS AG in the interactive database Compare manager voting policies
These tallies are CRISPR THERAPEUTICS AG’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. Approval of the Swiss Management Report, the Consolidated Financial Statements and the Statutory Financial Statements of the Company for the Year Ended December 31, 2025 | 70,716,663 | 288,652 | 248,393 | -- | 0 | 99.6% | Approved | — |
| 2. Approval of the Appropriation of Financial Results | 70,554,606 | 415,599 | 283,503 | -- | 0 | 99.4% | Approved | — |
| 3. Discharge of the Members of the Company’s Board of Directors and Executive Committee | 48,379,678 | 262,761 | 112,414 | -- | 22,498,855 | 99.5% | Approved | — |
| Elect Director: Samarth Kulkarni, Ph.D. | 47,043,987 | 1,628,226 | 82,640 | -- | 22,498,855 | 97% | Elected | — |
| Elect Director: Ali Behbahani, M.D. | 35,498,392 | 13,174,523 | 81,938 | -- | 22,498,855 | 73% | Elected | — |
| Elect Director: Maria Fardis, Ph.D. | 47,804,457 | 874,207 | 76,189 | -- | 22,498,855 | 98% | Elected | — |
| Elect Director: H. Edward Fleming Jr., M.D. | 46,977,636 | 1,686,127 | 91,090 | -- | 22,498,855 | 97% | Elected | — |
| Elect Director: Simeon J. George, M.D. | 47,435,748 | 1,225,519 | 93,586 | -- | 22,498,855 | 97% | Elected | — |
| Elect Director: John T. Greene | 46,876,367 | 1,793,109 | 85,377 | -- | 22,498,855 | 96% | Elected | — |
| Elect Director: Katherine A. High, M.D. | 47,779,619 | 899,787 | 75,447 | -- | 22,498,855 | 98% | Elected | — |
| Elect Director: Sandesh Mahatme, LL.M. | 46,268,964 | 2,405,580 | 80,309 | -- | 22,498,855 | 95% | Elected | — |
| Elect Director: Briggs W. Morrison, M.D. | 46,013,911 | 2,659,681 | 81,261 | -- | 22,498,855 | 95% | Elected | — |
| Elect Director: Christian Rommel, Ph.D. | 47,802,202 | 872,050 | 80,601 | -- | 22,498,855 | 98% | Elected | — |
| Elect Director: Douglas A. Treco, Ph.D. | 44,359,453 | 4,317,384 | 78,016 | -- | 22,498,855 | 91% | Elected | — |
| Elect Director: Ali Behbahani, M.D. | 35,458,908 | 13,198,641 | 97,304 | -- | 22,498,855 | 73% | Elected | — |
| Elect Director: H. Edward Fleming Jr., M.D. | 46,322,476 | 2,341,513 | 90,864 | -- | 22,498,855 | 95% | Elected | — |
| Elect Director: John T. Greene | 46,319,646 | 2,326,146 | 109,061 | -- | 22,498,855 | 95% | Elected | — |
| Elect Director: Briggs W. Morrison, M.D. | 45,317,635 | 3,329,265 | 107,953 | -- | 22,498,855 | 93% | Elected | — |
| 7. Non-Binding Advisory Vote on the Compensation Paid to the Company’s Named Executive Officers Under U.S. Securities Law Requirements | 33,742,001 | 14,867,591 | 145,261 | -- | 22,498,855 | 69% | Approved | — |
| 8. Approval of an Increase to the Company’s Capital Band | 69,408,999 | 1,361,697 | 483,012 | -- | 0 | 98% | Approved | — |
| 9. Approval of an Increase to the Conditional Share Capital for the Conversion of Bonds and Similar Debt Instruments | 47,341,035 | 1,298,782 | 115,036 | -- | 22,498,855 | 97% | Approved | — |
| 10. Approval of the 2026 Plan | 42,839,199 | 5,763,564 | 152,090 | -- | 22,498,855 | 88% | Approved | — |
| 11. Re-election of the Independent Voting Rights Representative | 70,290,203 | 640,943 | 322,562 | -- | 0 | 99.1% | Passed (calculated) | — |
| 12. Re-election of the Auditors | 69,875,653 | 462,910 | 915,145 | -- | 0 | 99.3% | Passed (calculated) | — |
| 13. Transact Any Other Business that may Properly Come Before the 2026 Annual General Meeting or any Adjournment or Postponement thereof | 29,000,337 | 19,464,339 | 290,177 | -- | 22,498,855 | 60% | Approved | — |
Source: CRISPR THERAPEUTICS AG, Form 8-K, filed with the SEC on June 4, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
513 asset managers disclosed a vote on at least one CRISPR THERAPEUTICS AG item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CRISPR THERAPEUTICS AG’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
89% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: BINDING VOTE ON MAXIMUM EQUITY FOR MEMBERS OF THE BOARD OF DIRECTORS FROM THE 2026 ANNUAL GENERAL MEETING TO THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 557,037 | 0 | 0 | Against |
| Vanguard | 286,372 | 1,394 | 0 | 0 | For |
| State Street | 0 | 198,049 | 0 | 0 | Against |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| Equitable | 13,278 | 122,735 | 0 | 0 | Mixed |
| Lincoln Financial | 6,490 | 128,668 | 0 | 0 | Against |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| American Century | 0 | 59,438 | 0 | 0 | Against |
| RMB INVESTORS TRUST | 0 | 37,600 | 0 | 0 | Against |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 32,826 | 0 | 0 | Against |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 22,300 | 0 | 0 | Against |
| Global X | 0 | 17,975 | 0 | 0 | Against |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 16,046 | 0 | 0 | Against |
| SEI | 0 | 14,652 | 0 | 0 | Against |
| ProShares | 0 | 13,143 | 0 | 0 | Against |
| TARGET PORTFOLIO TRUST | 12,900 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 11,658 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 10,973 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 9,396 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 0 | 8,432 | 0 | 0 | Against |
Fund voting reports, all 52 managers: 7,321,136 for, 1,305,188 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 2,038,763 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 1,060,002 | 0 | 0 | 0 | For |
| Versant Venture Management, LLC | 148,831 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 0 | 24,211 | 0 | 0 | Against |
| Ipswich Investment Management Co., Inc. | 15,673 | 0 | 0 | 0 | For |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 0 | 4,945 | 0 | 0 | Against |
| HOLDERNESS INVESTMENTS CO | 2,469 | 0 | 0 | 0 | For |
| SevenBridge Financial Group, LLC | 2,150 | 0 | 0 | 0 | For |
| Vident Advisory, LLC | 2,120 | 0 | 0 | 0 | For |
| Atlantic Union Bankshares Corp | 1,566 | 0 | 0 | 0 | For |
| Waverly Advisors, LLC | 1,532 | 0 | 0 | 0 | For |
| Bogart Wealth, LLC | 1,250 | 0 | 0 | 0 | For |
| Sound View Wealth Advisors Group, LLC | 1,214 | 0 | 0 | 0 | For |
| Formidable Asset Management, LLC | 1,190 | 0 | 0 | 0 | For |
| ZACKS INVESTMENT MANAGEMENT | 862 | 0 | 0 | 0 | For |
| DDD Partners, LLC | 819 | 0 | 0 | 0 | For |
| WIMMER ASSOCIATES 1, LLC | 650 | 0 | 0 | 0 | For |
| MERIDIAN INVESTMENT COUNSEL INC. | 575 | 0 | 0 | 0 | For |
| Journey Advisory Group, LLC | 500 | 0 | 0 | 0 | For |
| Naviter Wealth, LLC | 350 | 0 | 0 | 0 | For |
| CARY STREET PARTNERS FINANCIAL LLC | 340 | 0 | 0 | 0 | For |
| Summit Trail Advisors, LLC | 0 | 338 | 0 | 0 | Against |
| Legacy Capital Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
| Performance Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
| Rodgers Brothers Inc. | 0 | 300 | 0 | 0 | Against |
Institutional-manager reports, all 51 managers: 3,283,860 for, 30,193 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
94% of fund votes cast · no official result
The 77 asset managers below reported 11,106,682 for, 664,822 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 557,037 | 0 | 0 | Against |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 16,747 | 0 | 0 | Against |
| Ipswich Investment Management Co., Inc. | 15,673 | 0 | 0 | 0 | For |
| SEI | 14,652 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 12,900 | 0 | 0 | 0 | For |
| Russell Investments | 11,658 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 6,757 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 6,490 | 0 | 0 | Against |
| Loomis Sayles | 0 | 5,310 | 0 | 0 | Against |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 4,945 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 3,800 | 0 | 0 | 0 | For |
| EA Series Trust | 3,562 | 0 | 0 | 0 | For |
| Vanguard | 3,282 | 3 | 0 | 0 | For |
| HOLDERNESS INVESTMENTS CO | 2,469 | 0 | 0 | 0 | For |
| SevenBridge Financial Group, LLC | 2,150 | 0 | 0 | 0 | For |
| Allianz | 0 | 2,134 | 0 | 0 | Against |
Showing the 25 largest of 77 asset managers. All 77 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.5% Approved · of votes cast
Description as filed by funds: Discharge of the members of the Board of Directors and the Executive Committee.
CRISPR THERAPEUTICS AG’s own tally for this item (“3. Discharge of the Members of the Company’s Board of Directors and Executive Committee”): 48,379,678 for, 262,761 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Discharge of the Members of the Company’s Board of Directors and Executive Committee The discharge of the members of the Company’s Board of Directors and the Executive Committee from personal liability for their activities during the year ended December 31, 2025 was approved.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 75 asset managers below reported 19,691,680 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,766 | 0 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 136,013 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,158 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 76,100 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 75 asset managers. All 75 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Re-election of the independent voting rights representative.
CRISPR THERAPEUTICS AG’s own tally for this item (“11. Re-election of the Independent Voting Rights Representative”): 70,290,203 for, 640,943 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 19,676,391 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,766 | 0 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 136,013 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,158 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 76,100 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 98.1% for (June 5, 2025 meeting) ▼ 1.4 pts
Description as filed by funds: Re-election of the members to the Board of Directors and the Chairman: Re-election of Samarth Kulkarni, Ph.D., as member and Chairman
CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Samarth Kulkarni, Ph.D.”): 47,043,987 for, 1,628,226 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 19,375,839 for, 300,552 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 286,376 | 1,390 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 13,278 | 122,735 | 0 | 0 | Mixed |
| Lincoln Financial | 78,121 | 57,037 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 22,300 | 0 | 0 | Against |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.8% for (June 5, 2025 meeting) ▲ 0.4 pts
Description as filed by funds: Re-election of Maria Fardis, Ph.D.
CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Maria Fardis, Ph.D.”): 47,804,457 for, 874,207 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 19,477,753 for, 198,637 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 286,708 | 1,057 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 77,368 | 58,645 | 0 | 0 | Mixed |
| Lincoln Financial | 80,248 | 54,910 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 97.8% for (June 5, 2025 meeting) ▼ 0.3 pts
Description as filed by funds: Re-election of Simeon J. George, M.D.
CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Simeon J. George, M.D.”): 47,435,748 for, 1,225,519 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 19,455,129 for, 221,262 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,765 | 1 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 77,368 | 58,645 | 0 | 0 | Mixed |
| Lincoln Financial | 73,758 | 61,400 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 16,747 | 0 | 0 | Against |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.7% for (June 5, 2025 meeting) ▲ 0.5 pts
Description as filed by funds: Re-election of Katherine A. High, M.D.
CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Katherine A. High, M.D.”): 47,779,619 for, 899,787 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 19,471,893 for, 204,498 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,766 | 0 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 77,368 | 58,645 | 0 | 0 | Mixed |
| Lincoln Financial | 80,248 | 54,910 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Prior year: 97.8% for (June 5, 2025 meeting) ▼ 2.7 pts
Description as filed by funds: Re-election of Sandesh Mahatme, LL.M.
CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Sandesh Mahatme, LL.M.”): 46,268,964 for, 2,405,580 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 18,847,258 for, 829,133 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 557,037 | 0 | 0 | Against |
| Vanguard | 286,376 | 1,390 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 77,368 | 58,645 | 0 | 0 | Mixed |
| Lincoln Financial | 80,248 | 54,910 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 22,300 | 0 | 0 | Against |
| Global X | 0 | 17,975 | 0 | 0 | Against |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.8% for (June 5, 2025 meeting) ▲ 0.4 pts
Description as filed by funds: Re-election of Christian Rommel, Ph.D.
CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Christian Rommel, Ph.D.”): 47,802,202 for, 872,050 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 19,479,368 for, 197,023 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,766 | 0 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 77,368 | 58,645 | 0 | 0 | Mixed |
| Lincoln Financial | 80,248 | 54,910 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Prior year: 95.4% for (June 5, 2025 meeting) ▼ 4.2 pts
Description as filed by funds: Re-election of Douglas A. Treco, Ph.D.
CRISPR THERAPEUTICS AG’s own tally for this item (“Elect Director: Douglas A. Treco, Ph.D.”): 44,359,453 for, 4,317,384 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 4 – Re-election of the Members to the Board of Directors and the Chairman Samarth Kulkarni, Ph.D., Ali Behbahani, M.D., Maria Fardis, Ph.D., H. Edward Fleming Jr., M.D., Simeon J. George, M.D., John T. Greene, Katherine A. High, M.D., Sandesh Mahatme, LL.M., Briggs W. Morrison, M.D., Chris…”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 18,252,000 for, 1,424,390 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 46,415 | 861,729 | 0 | 0 | Mixed |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 286,706 | 1,059 | 0 | 0 | For |
| State Street | 0 | 198,049 | 0 | 0 | Against |
| Fidelity | 138,929 | 38,814 | 0 | 0 | Mixed |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 64,090 | 71,923 | 0 | 0 | Mixed |
| Lincoln Financial | 21,348 | 113,810 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 40,875 | 0 | 0 | Against |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Binding vote on maximum non- performance-related compensation for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| SEI | 14,652 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 12,900 | 0 | 0 | 0 | For |
| Russell Investments | 11,658 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 6,757 | 0 | 0 | 0 | For |
| Lincoln Financial | 6,490 | 0 | 0 | 0 | For |
| Vanguard | 3,285 | 0 | 0 | 0 | For |
| Nationwide | 1,990 | 0 | 0 | 0 | For |
| New York Life | 1,173 | 0 | 0 | 0 | For |
| Brighthouse | 1,001 | 0 | 0 | 0 | For |
| Prudential/PGIM | 400 | 0 | 0 | 0 | For |
| Meeder Funds | 144 | 0 | 0 | 0 | For |
| NYLIM VP FUNDS TRUST | 7 | 0 | 0 | 0 | For |
Fund voting reports, all 17 managers: 705,516 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 2,038,763 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 1,060,002 | 0 | 0 | 0 | For |
| Versant Venture Management, LLC | 148,831 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 24,211 | 0 | 0 | 0 | For |
| Ipswich Investment Management Co., Inc. | 15,673 | 0 | 0 | 0 | For |
| Jasper Ridge Partners, L.P. | 9,539 | 0 | 0 | 0 | For |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 4,945 | 0 | 0 | 0 | For |
| HOLDERNESS INVESTMENTS CO | 2,469 | 0 | 0 | 0 | For |
| SevenBridge Financial Group, LLC | 2,150 | 0 | 0 | 0 | For |
| Atlantic Union Bankshares Corp | 1,566 | 0 | 0 | 0 | For |
| Waverly Advisors, LLC | 1,532 | 0 | 0 | 0 | For |
| Bogart Wealth, LLC | 1,250 | 0 | 0 | 0 | For |
| Sound View Wealth Advisors Group, LLC | 1,214 | 0 | 0 | 0 | For |
| Formidable Asset Management, LLC | 1,190 | 0 | 0 | 0 | For |
| ZACKS INVESTMENT MANAGEMENT | 862 | 0 | 0 | 0 | For |
| DDD Partners, LLC | 819 | 0 | 0 | 0 | For |
| WIMMER ASSOCIATES 1, LLC | 650 | 0 | 0 | 0 | For |
| MERIDIAN INVESTMENT COUNSEL INC. | 575 | 0 | 0 | 0 | For |
| Journey Advisory Group, LLC | 500 | 0 | 0 | 0 | For |
| BIRCHBROOK, INC. | 455 | 0 | 0 | 0 | For |
| Naviter Wealth, LLC | 350 | 0 | 0 | 0 | For |
| CARY STREET PARTNERS FINANCIAL LLC | 340 | 0 | 0 | 0 | For |
| Summit Trail Advisors, LLC | 338 | 0 | 0 | 0 | For |
| Legacy Capital Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
| Performance Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
Institutional-manager reports, all 51 managers: 3,321,627 for. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
90% of fund votes cast · no official result
The 57 asset managers below reported 8,290,485 for, 904,174 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 557,037 | 0 | 0 | Mixed |
| Vanguard | 286,706 | 1,059 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 38,814 | 138,929 | 0 | 0 | Mixed |
| Equitable | 13,278 | 122,735 | 0 | 0 | Mixed |
| Lincoln Financial | 71,631 | 63,527 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 16,747 | 0 | 0 | Against |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
| SEI | 14,652 | 0 | 0 | 0 | For |
| ProShares | 13,143 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 12,900 | 0 | 0 | 0 | For |
| Russell Investments | 11,658 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 10,973 | 0 | 0 | 0 | For |
| Jasper Ridge Partners, L.P. | 9,539 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 9,396 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
67% of fund votes cast · no official result
The 56 asset managers below reported 5,806,524 for, 2,821,560 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 246 | 1,225,262 | 0 | 0 | Against |
| Charles Schwab | 0 | 557,037 | 0 | 0 | Against |
| Vanguard | 1,890 | 285,876 | 0 | 0 | Against |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 0 | 177,743 | 0 | 0 | Against |
| Equitable | 0 | 136,013 | 0 | 0 | Against |
| Lincoln Financial | 58,900 | 76,258 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| American Century | 0 | 59,438 | 0 | 0 | Against |
| RMB INVESTORS TRUST | 0 | 37,600 | 0 | 0 | Against |
| Northwestern Mutual | 0 | 33,247 | 0 | 0 | Against |
| Guggenheim | 0 | 32,826 | 0 | 0 | Against |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 22,300 | 0 | 0 | Against |
| Global X | 0 | 17,975 | 0 | 0 | Against |
| JPMorgan | 0 | 16,747 | 0 | 0 | Against |
| ETFis Series Trust I | 0 | 16,046 | 0 | 0 | Against |
| SEI | 0 | 14,652 | 0 | 0 | Against |
| ProShares | 0 | 13,143 | 0 | 0 | Against |
| TARGET PORTFOLIO TRUST | 0 | 12,900 | 0 | 0 | Against |
| Russell Investments | 0 | 11,658 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 10,973 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 9,396 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 0 | 8,432 | 0 | 0 | Against |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
90% of fund votes cast · no official result
The 56 asset managers below reported 8,282,304 for, 904,206 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 557,037 | 0 | 0 | Mixed |
| Vanguard | 287,764 | 1,391 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 38,814 | 138,929 | 0 | 0 | Mixed |
| Equitable | 13,278 | 122,735 | 0 | 0 | Mixed |
| Lincoln Financial | 71,631 | 63,527 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 16,747 | 0 | 0 | Against |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
| SEI | 14,652 | 0 | 0 | 0 | For |
| ProShares | 13,143 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 12,900 | 0 | 0 | 0 | For |
| Russell Investments | 11,658 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 10,973 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 9,396 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 8,432 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
93% of fund votes cast · no official result
The 55 asset managers below reported 8,022,929 for, 605,085 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,764 | 2 | 0 | 0 | For |
| State Street | 0 | 198,049 | 0 | 0 | Against |
| Fidelity | 38,814 | 138,929 | 0 | 0 | Mixed |
| Equitable | 13,278 | 122,735 | 0 | 0 | Mixed |
| Lincoln Financial | 12,731 | 122,427 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 16,747 | 0 | 0 | Against |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
| SEI | 14,652 | 0 | 0 | 0 | For |
| ProShares | 13,143 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 12,900 | 0 | 0 | 0 | For |
| Russell Investments | 11,658 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 10,973 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 9,396 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 8,432 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. All 55 are in the interactive database (link above).
73% of fund votes cast · no official result
The 41 asset managers below reported 5,771,944 for, 2,148,864 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 246 | 1,225,262 | 0 | 0 | Against |
| Vanguard | 0 | 284,481 | 0 | 0 | Against |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 0 | 177,743 | 0 | 0 | Against |
| Equitable | 0 | 136,013 | 0 | 0 | Against |
| Lincoln Financial | 58,900 | 69,768 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| American Century | 0 | 59,438 | 0 | 0 | Against |
| RMB INVESTORS TRUST | 0 | 37,600 | 0 | 0 | Against |
| Northwestern Mutual | 0 | 33,247 | 0 | 0 | Against |
| Guggenheim | 0 | 32,826 | 0 | 0 | Against |
| ETFis Series Trust I | 0 | 16,046 | 0 | 0 | Against |
| ProShares | 0 | 13,143 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 10,973 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 9,396 | 0 | 0 | Against |
| Calvert | 0 | 7,475 | 0 | 0 | Against |
| Franklin Templeton | 0 | 6,651 | 0 | 0 | Against |
| Voya | 0 | 5,728 | 0 | 0 | Against |
| Allspring | 0 | 3,864 | 0 | 0 | Against |
| Morgan Stanley | 0 | 3,509 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 3,400 | 0 | 0 | Against |
| Nationwide | 0 | 2,575 | 0 | 0 | Against |
| PENN SERIES FUNDS INC | 2,332 | 0 | 0 | 0 | For |
| TIAA | 0 | 1,795 | 0 | 0 | Against |
Showing the 25 largest of 41 asset managers. All 41 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
86% of fund votes cast · no official result
The 35 asset managers below reported 10,041,772 for, 1,691,297 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| BlackRock | 0 | 908,144 | 0 | 0 | Against |
| Charles Schwab | 0 | 557,037 | 0 | 0 | Against |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 40,875 | 0 | 0 | Against |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Global X | 0 | 17,975 | 0 | 0 | Against |
| John Hancock | 0 | 17,087 | 0 | 0 | Against |
| JPMorgan | 0 | 16,747 | 0 | 0 | Against |
| SEI | 0 | 14,652 | 0 | 0 | Against |
| TARGET PORTFOLIO TRUST | 12,900 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 11,658 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 0 | 6,757 | 0 | 0 | Against |
| Lincoln Financial | 0 | 6,490 | 0 | 0 | Against |
| Loomis Sayles | 0 | 5,310 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 3,800 | 0 | 0 | Against |
| EA Series Trust | 3,562 | 0 | 0 | 0 | For |
| Vanguard | 1,890 | 1,395 | 0 | 0 | Mixed |
| Allianz | 0 | 2,134 | 0 | 0 | Against |
| Nationwide | 0 | 1,990 | 0 | 0 | Against |
| Formidable Asset Management, LLC | 1,190 | 0 | 0 | 0 | For |
| New York Life | 0 | 1,173 | 0 | 0 | Against |
| Brighthouse | 0 | 1,001 | 0 | 0 | Against |
Showing the 25 largest of 35 asset managers. All 35 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.0% of fund votes cast · no official result
The 25 asset managers below reported 10,996,916 for, 109,398 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 16,747 | 0 | 0 | Against |
| Lincoln Financial | 0 | 6,490 | 0 | 0 | Against |
| Loomis Sayles | 0 | 5,310 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 3,800 | 0 | 0 | 0 | For |
| EA Series Trust | 3,562 | 0 | 0 | 0 | For |
| Allianz | 0 | 2,134 | 0 | 0 | Against |
| Formidable Asset Management, LLC | 1,190 | 0 | 0 | 0 | For |
| Vanguard | 20 | 1,059 | 0 | 0 | Against |
| Brighthouse | 0 | 1,001 | 0 | 0 | Against |
| REYNOLDS FUNDS INC | 700 | 0 | 0 | 0 | For |
| Jackson National | 511 | 0 | 0 | 0 | For |
| Crewe Advisors LLC | 350 | 0 | 0 | 0 | For |
| Legacy Capital Wealth Partners, LLC | 0 | 300 | 0 | 0 | Against |
| Amplify ETF Trust | 0 | 257 | 0 | 0 | Against |
| Roberts Wealth Advisors, LLC | 200 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 197 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 41 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
99.0% of fund votes cast · no official result
The 25 asset managers below reported 10,998,530 for, 107,784 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 16,747 | 0 | 0 | Against |
| Lincoln Financial | 0 | 6,490 | 0 | 0 | Against |
| Loomis Sayles | 0 | 5,310 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 3,800 | 0 | 0 | 0 | For |
| EA Series Trust | 3,562 | 0 | 0 | 0 | For |
| Allianz | 0 | 2,134 | 0 | 0 | Against |
| Formidable Asset Management, LLC | 1,190 | 0 | 0 | 0 | For |
| Vanguard | 1,077 | 2 | 0 | 0 | For |
| Brighthouse | 0 | 1,001 | 0 | 0 | Against |
| REYNOLDS FUNDS INC | 700 | 0 | 0 | 0 | For |
| Jackson National | 511 | 0 | 0 | 0 | For |
| Crewe Advisors LLC | 350 | 0 | 0 | 0 | For |
| Legacy Capital Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 257 | 0 | 0 | 0 | For |
| Roberts Wealth Advisors, LLC | 200 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 197 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 41 | 0 | 0 | 0 | For |
Combines 4 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: Approval of an increase to the conditional share capital for the conversion of bonds and similar debt instruments.
CRISPR THERAPEUTICS AG’s own tally for this item (“9. Approval of an Increase to the Conditional Share Capital for the Conversion of Bonds and Similar Debt Instruments”): 47,341,035 for, 1,298,782 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 9 – Approval of an Increase to the Conditional Share Capital for the Conversion of Bonds and Similar Debt Instruments An increase to the conditional share capital for the conversion of bonds and similar debt instruments was approved with at least two thirds of the votes represented and the…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 19,424,085 for, 259,306 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,765 | 1 | 0 | 0 | For |
| State Street | 0 | 198,049 | 0 | 0 | Against |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 136,013 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,258 | 58,900 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 76,100 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: Approval of an increase to the Company's capital band.
CRISPR THERAPEUTICS AG’s own tally for this item (“8. Approval of an Increase to the Company’s Capital Band”): 69,408,999 for, 1,361,697 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 8 – Approval of an Increase to the Company’s Capital Band An increase to the Company’s capital band was approved with at least two thirds of the votes represented and the absolute majority of the par value of the represented shares.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 19,672,829 for, 3,562 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,766 | 0 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 136,013 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,158 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 76,100 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: Approval of the Swiss management report, the consolidated financial statements and the statutory financial statements of the Company for the year ended December 31, 2025.
CRISPR THERAPEUTICS AG’s own tally for this item (“1. Approval of the Swiss Management Report, the Consolidated Financial Statements and the Statutory Financial Statements of the Company for the Year Ended December 31, 2025”): 70,716,663 for, 288,652 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 1 – Approval of the Swiss Management Report, the Consolidated Financial Statements and the Statutory Financial Statements of the Company for the Year Ended December 31, 2025 The Swiss management report, the consolidated financial statements and the statutory financial statements of the Com…”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 75 asset managers below reported 19,683,416 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,766 | 0 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 136,013 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,158 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 76,100 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 75 asset managers. All 75 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.4% Approved · of votes cast
Description as filed by funds: Approval of the appropriation of financial results.
CRISPR THERAPEUTICS AG’s own tally for this item (“2. Approval of the Appropriation of Financial Results”): 70,554,606 for, 415,599 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Approval of the Appropriation of Financial Results The proposal to carry forward the net loss resulting from the appropriation of financial results was approved.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 74 asset managers below reported 19,676,416 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,766 | 0 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 136,013 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,158 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 76,100 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
60% Approved · of votes cast
Description as filed by funds: Transact any other business that may properly come before the 2026 Annual General Meeting or any adjournment or postponement thereof.
CRISPR THERAPEUTICS AG’s own tally for this item (“13. Transact Any Other Business that may Properly Come Before the 2026 Annual General Meeting or any Adjournment or Postponement thereof”): 29,000,337 for, 19,464,339 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 13 – Transact Any Other Business that may Properly Come Before the 2026 Annual General Meeting or any Adjournment or Postponement thereof The proposal for the transaction of any other business that properly came before the Annual Meeting or any adjournment or postponement thereof, to follo…”
Support: 60% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 15,559,697 for, 4,116,693 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 1,225,508 | 0 | 0 | Against |
| BlackRock | 0 | 908,144 | 0 | 0 | Against |
| Charles Schwab | 0 | 557,037 | 0 | 0 | Against |
| Vanguard | 829 | 286,936 | 0 | 0 | Against |
| State Street | 0 | 198,049 | 0 | 0 | Against |
| Fidelity | 0 | 177,743 | 0 | 0 | Against |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 0 | 136,013 | 0 | 0 | Against |
| Lincoln Financial | 6,490 | 128,668 | 0 | 0 | Against |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| American Century | 0 | 59,438 | 0 | 0 | Against |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 40,875 | 0 | 0 | Against |
| RMB INVESTORS TRUST | 0 | 37,600 | 0 | 0 | Against |
| Northwestern Mutual | 0 | 33,247 | 0 | 0 | Against |
| Guggenheim | 0 | 32,826 | 0 | 0 | Against |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 22,300 | 0 | 0 | Against |
| Global X | 0 | 17,975 | 0 | 0 | Against |
| John Hancock | 0 | 17,087 | 0 | 0 | Against |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 16,046 | 0 | 0 | Against |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
96% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: BINDING VOTE ON MAXIMUM VARIABLE COMPENSATION FOR MEMBERS OF THE EXECUTIVE COMMITTEE FOR THE CURRENT YEAR ENDING DECEMBER 31, 2026.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,262 | 246 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,762 | 4 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 38,814 | 138,929 | 0 | 0 | Mixed |
| Equitable | 71,923 | 64,090 | 0 | 0 | Mixed |
| Lincoln Financial | 120,300 | 14,858 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| American Century | 0 | 59,438 | 0 | 0 | Against |
| RMB INVESTORS TRUST | 0 | 37,600 | 0 | 0 | Against |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 32,826 | 0 | 0 | Against |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 16,046 | 0 | 0 | Against |
| SEI | 14,652 | 0 | 0 | 0 | For |
| ProShares | 0 | 13,143 | 0 | 0 | Against |
| TARGET PORTFOLIO TRUST | 12,900 | 0 | 0 | 0 | For |
| Russell Investments | 11,658 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 10,973 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 9,396 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 6,757 | 1,675 | 0 | 0 | Mixed |
Fund voting reports, all 52 managers: 8,197,690 for, 428,634 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 2,038,763 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 1,060,002 | 0 | 0 | 0 | For |
| Versant Venture Management, LLC | 148,831 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 24,211 | 0 | 0 | 0 | For |
| Jasper Ridge Partners, L.P. | 9,539 | 0 | 0 | 0 | For |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 4,945 | 0 | 0 | 0 | For |
| HOLDERNESS INVESTMENTS CO | 2,469 | 0 | 0 | 0 | For |
| SevenBridge Financial Group, LLC | 2,150 | 0 | 0 | 0 | For |
| Vident Advisory, LLC | 2,120 | 0 | 0 | 0 | For |
| Atlantic Union Bankshares Corp | 1,566 | 0 | 0 | 0 | For |
| Waverly Advisors, LLC | 1,532 | 0 | 0 | 0 | For |
| Bogart Wealth, LLC | 1,250 | 0 | 0 | 0 | For |
| Sound View Wealth Advisors Group, LLC | 1,214 | 0 | 0 | 0 | For |
| Formidable Asset Management, LLC | 1,190 | 0 | 0 | 0 | For |
| ZACKS INVESTMENT MANAGEMENT | 862 | 0 | 0 | 0 | For |
| DDD Partners, LLC | 819 | 0 | 0 | 0 | For |
| WIMMER ASSOCIATES 1, LLC | 650 | 0 | 0 | 0 | For |
| MERIDIAN INVESTMENT COUNSEL INC. | 575 | 0 | 0 | 0 | For |
| Journey Advisory Group, LLC | 500 | 0 | 0 | 0 | For |
| BIRCHBROOK, INC. | 455 | 0 | 0 | 0 | For |
| Naviter Wealth, LLC | 350 | 0 | 0 | 0 | For |
| CARY STREET PARTNERS FINANCIAL LLC | 340 | 0 | 0 | 0 | For |
| Summit Trail Advisors, LLC | 338 | 0 | 0 | 0 | For |
| Legacy Capital Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
| Performance Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
Institutional-manager reports, all 50 managers: 3,307,943 for, 10 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
88% Approved · of votes cast
Description as filed by funds: Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan.
CRISPR THERAPEUTICS AG’s own tally for this item (“10. Approval of the 2026 Plan”): 42,839,199 for, 5,763,564 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 10 – Approval of the 2026 Plan The 2026 Plan was approved.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,763 | 3 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 136,013 | 0 | 0 | 0 | For |
| Lincoln Financial | 120,300 | 14,858 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 76,100 | 0 | 0 | 0 | For |
| American Century | 0 | 59,438 | 0 | 0 | Against |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 0 | 37,600 | 0 | 0 | Against |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 32,826 | 0 | 0 | Against |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 134 | 16,953 | 0 | 0 | Against |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 16,046 | 0 | 0 | Against |
Fund voting reports, all 68 managers: 19,418,451 for, 255,830 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 1,060,002 | 0 | 0 | 0 | For |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 4,945 | 0 | 0 | 0 | For |
| Vident Advisory, LLC | 2,120 | 0 | 0 | 0 | For |
| Formidable Asset Management, LLC | 1,190 | 0 | 0 | 0 | For |
| BIRCHBROOK, INC. | 455 | 0 | 0 | 0 | For |
| Crewe Advisors LLC | 350 | 0 | 0 | 0 | For |
| Legacy Capital Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
| Roberts Wealth Advisors, LLC | 200 | 0 | 0 | 0 | For |
| Royal Capital Wealth Management, LLC | 131 | 0 | 0 | 0 | For |
| CHECK CAPITAL MANAGEMENT INC/CA | 100 | 0 | 0 | 0 | For |
| MARCO INVESTMENT MANAGEMENT LLC | 70 | 0 | 0 | 0 | For |
| Socha Financial Group, LLC | 25 | 0 | 0 | 0 | For |
| Hendershot Investments Inc. | 0 | 10 | 0 | 0 | Against |
Institutional-manager reports, all 13 managers: 1,069,888 for, 10 against.
Combines 20 wordings of this item as funds reported it.
69% Approved · of votes cast
Prior year: 71.2% for (June 5, 2025 meeting) ▼ 1.8 pts
Description as filed by funds: NON-BINDING ADVISORY VOTE ON THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS UNDER U.S. SECURITIES LAW REQUIREMENTS.
CRISPR THERAPEUTICS AG’s own tally for this item (“7. Non-Binding Advisory Vote on the Compensation Paid to the Company’s Named Executive Officers Under U.S. Securities Law Requirements”): 33,742,001 for, 14,867,591 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 7 – Non-Binding Advisory Vote on the Compensation Paid to the Company’s Named Executive Officers Under U.S. Securities Law Requirements The compensation paid to the named executive officers was approved on a non-binding basis.”
Support: 69% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 0 | 5,387,072 | 0 | 0 | Against |
| T. Rowe Price | 1,225,262 | 246 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 557,037 | 0 | 0 | Against |
| Vanguard | 286,372 | 1,394 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 38,814 | 138,929 | 0 | 0 | Mixed |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 13,278 | 122,735 | 0 | 0 | Mixed |
| Lincoln Financial | 65,390 | 69,768 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 0 | 76,100 | 0 | 0 | Against |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 0 | 37,600 | 0 | 0 | Against |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 32,826 | 0 | 0 | Against |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 22,300 | 0 | 0 | Against |
| Global X | 0 | 17,975 | 0 | 0 | Against |
| John Hancock | 134 | 16,953 | 0 | 0 | Against |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 16,046 | 0 | 0 | Against |
Fund voting reports, all 70 managers: 13,062,643 for, 6,620,958 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 150 | 6,029,384 | 0 | 0 | Against |
| SR ONE CAPITAL MANAGEMENT, LP | 2,038,763 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,811,725 | 112,806 | 0 | 0 | Mixed |
| Amova Asset Management Co., Ltd. | 0 | 1,835,407 | 0 | 0 | Against |
| BlackRock | 1,217,142 | 5,721 | 0 | 0 | For |
| NEA Management Company, LLC | 1,060,002 | 0 | 0 | 0 | For |
| State Street | 850,282 | 5,863 | 0 | 0 | For |
| Charles Schwab | 0 | 557,219 | 0 | 0 | Against |
| ARK Investment Management LLC | 549,000 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 544,763 | 0 | 0 | Against |
| Northern Trust | 0 | 403,093 | 0 | 0 | Against |
| Green Alpha Advisors, LLC | 0 | 271,425 | 0 | 0 | Against |
| Vestmark Advisory Solutions, Inc. | 0 | 251,455 | 0 | 0 | Against |
| Fidelity | 0 | 215,616 | 0 | 0 | Against |
| WELLS FARGO CLEARING SERVICES, LLC | 162,856 | 0 | 0 | 0 | For |
| Versant Venture Management, LLC | 148,831 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 146,580 | 0 | 0 | 0 | For |
| RBC Capital Markets, LLC | 0 | 140,405 | 0 | 0 | Against |
| Vanguard | 122,125 | 1,399 | 0 | 0 | For |
| UBS | 0 | 119,974 | 0 | 0 | Against |
| Reynders McVeigh Capital Management, LLC | 0 | 106,533 | 0 | 0 | Against |
| AllianceBernstein | 0 | 94,286 | 0 | 0 | Against |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 0 | 82,547 | 0 | 0 | Against |
| ROCKEFELLER FINANCIAL LLC | 71,576 | 0 | 0 | 0 | For |
| Edward D. Jones & Co., L.P. | 0 | 61,462 | 0 | 0 | Against |
Institutional-manager reports, all 452 managers: 8,735,474 for, 12,228,900 against, 25,390 abstained, 40,889 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
91% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: NON-BINDING ADVISORY VOTE ON THE 2025 COMPENSATION REPORT.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,262 | 246 | 0 | 0 | For |
| Charles Schwab | 0 | 557,037 | 0 | 0 | Against |
| Vanguard | 286,372 | 1,394 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 38,814 | 138,929 | 0 | 0 | Mixed |
| Equitable | 13,278 | 122,735 | 0 | 0 | Mixed |
| Lincoln Financial | 65,390 | 69,768 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 0 | 37,600 | 0 | 0 | Against |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 32,826 | 0 | 0 | Against |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 22,300 | 0 | 0 | Against |
| Global X | 0 | 17,975 | 0 | 0 | Against |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 16,046 | 0 | 0 | Against |
| SEI | 0 | 14,652 | 0 | 0 | Against |
| ProShares | 0 | 13,143 | 0 | 0 | Against |
| TARGET PORTFOLIO TRUST | 12,900 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 11,658 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 10,973 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 9,396 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 0 | 8,432 | 0 | 0 | Against |
Fund voting reports, all 52 managers: 7,506,432 for, 1,119,892 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 2,038,763 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 1,060,002 | 0 | 0 | 0 | For |
| Versant Venture Management, LLC | 148,831 | 0 | 0 | 0 | For |
| Ipswich Investment Management Co., Inc. | 15,673 | 0 | 0 | 0 | For |
| Jasper Ridge Partners, L.P. | 9,539 | 0 | 0 | 0 | For |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 0 | 4,945 | 0 | 0 | Against |
| CWM, LLC | 4,498 | 0 | 0 | 0 | For |
| HOLDERNESS INVESTMENTS CO | 2,469 | 0 | 0 | 0 | For |
| Argent Trust Co | 0 | 2,361 | 0 | 0 | Against |
| SevenBridge Financial Group, LLC | 2,150 | 0 | 0 | 0 | For |
| Wealth Alliance Advisory Group, LLC | 2,144 | 0 | 0 | 0 | For |
| Vident Advisory, LLC | 2,120 | 0 | 0 | 0 | For |
| Atlantic Union Bankshares Corp | 1,566 | 0 | 0 | 0 | For |
| Waverly Advisors, LLC | 1,532 | 0 | 0 | 0 | For |
| Bogart Wealth, LLC | 1,250 | 0 | 0 | 0 | For |
| Bath Savings Trust Co | 1,225 | 0 | 0 | 0 | For |
| Sound View Wealth Advisors Group, LLC | 1,214 | 0 | 0 | 0 | For |
| Formidable Asset Management, LLC | 1,190 | 0 | 0 | 0 | For |
| ZACKS INVESTMENT MANAGEMENT | 862 | 0 | 0 | 0 | For |
| DDD Partners, LLC | 819 | 0 | 0 | 0 | For |
| AMERICAN NATIONAL BANK & TRUST | 0 | 0 | 800 | 0 | Abstain |
| WIMMER ASSOCIATES 1, LLC | 650 | 0 | 0 | 0 | For |
| Pine Valley Investments Ltd Liability Co | 600 | 0 | 0 | 0 | For |
| MERIDIAN INVESTMENT COUNSEL INC. | 575 | 0 | 0 | 0 | For |
| Argent Advisors, Inc. | 0 | 500 | 0 | 0 | Against |
Institutional-manager reports, all 72 managers: 3,302,940 for, 9,569 against, 1,173 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
96% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Binding vote on maximum non- performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,262 | 246 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,762 | 4 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 38,814 | 138,929 | 0 | 0 | Mixed |
| Equitable | 71,923 | 64,090 | 0 | 0 | Mixed |
| Lincoln Financial | 120,300 | 14,858 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| American Century | 0 | 59,438 | 0 | 0 | Against |
| RMB INVESTORS TRUST | 0 | 37,600 | 0 | 0 | Against |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 32,826 | 0 | 0 | Against |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 22,300 | 0 | 0 | 0 | For |
| Global X | 17,975 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 16,046 | 0 | 0 | Against |
| SEI | 14,652 | 0 | 0 | 0 | For |
| ProShares | 0 | 13,143 | 0 | 0 | Against |
| TARGET PORTFOLIO TRUST | 12,900 | 0 | 0 | 0 | For |
| Russell Investments | 11,658 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 10,973 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 9,396 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 6,757 | 1,675 | 0 | 0 | Mixed |
Fund voting reports, all 52 managers: 8,197,690 for, 428,634 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 2,038,763 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 1,060,002 | 0 | 0 | 0 | For |
| Versant Venture Management, LLC | 148,831 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 24,211 | 0 | 0 | 0 | For |
| Jasper Ridge Partners, L.P. | 9,539 | 0 | 0 | 0 | For |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 4,945 | 0 | 0 | 0 | For |
| HOLDERNESS INVESTMENTS CO | 2,469 | 0 | 0 | 0 | For |
| SevenBridge Financial Group, LLC | 2,150 | 0 | 0 | 0 | For |
| Vident Advisory, LLC | 2,120 | 0 | 0 | 0 | For |
| Atlantic Union Bankshares Corp | 1,566 | 0 | 0 | 0 | For |
| Waverly Advisors, LLC | 1,532 | 0 | 0 | 0 | For |
| Bogart Wealth, LLC | 1,250 | 0 | 0 | 0 | For |
| Sound View Wealth Advisors Group, LLC | 1,214 | 0 | 0 | 0 | For |
| Formidable Asset Management, LLC | 1,190 | 0 | 0 | 0 | For |
| ZACKS INVESTMENT MANAGEMENT | 862 | 0 | 0 | 0 | For |
| DDD Partners, LLC | 819 | 0 | 0 | 0 | For |
| WIMMER ASSOCIATES 1, LLC | 650 | 0 | 0 | 0 | For |
| MERIDIAN INVESTMENT COUNSEL INC. | 575 | 0 | 0 | 0 | For |
| Journey Advisory Group, LLC | 500 | 0 | 0 | 0 | For |
| BIRCHBROOK, INC. | 455 | 0 | 0 | 0 | For |
| Naviter Wealth, LLC | 350 | 0 | 0 | 0 | For |
| CARY STREET PARTNERS FINANCIAL LLC | 340 | 0 | 0 | 0 | For |
| Summit Trail Advisors, LLC | 338 | 0 | 0 | 0 | For |
| Legacy Capital Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
| Performance Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
Institutional-manager reports, all 50 managers: 3,307,643 for, 310 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
45% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: BINDING VOTE ON MAXIMUM EQUITY FOR MEMBERS OF THE EXECUTIVE COMMITTEE FROM THE 2026 ANNUAL GENERAL MEETING TO THE 2027 ANNUAL GENERAL MEETING OF SHAREHOLDERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 0 | 5,387,072 | 0 | 0 | Against |
| T. Rowe Price | 1,225,262 | 246 | 0 | 0 | For |
| Charles Schwab | 0 | 557,037 | 0 | 0 | Against |
| Vanguard | 286,372 | 1,394 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 38,814 | 138,929 | 0 | 0 | Mixed |
| Equitable | 13,278 | 122,735 | 0 | 0 | Mixed |
| Lincoln Financial | 65,390 | 69,768 | 0 | 0 | Mixed |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| American Century | 0 | 59,438 | 0 | 0 | Against |
| RMB INVESTORS TRUST | 0 | 37,600 | 0 | 0 | Against |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 32,826 | 0 | 0 | Against |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 22,300 | 0 | 0 | Against |
| Global X | 0 | 17,975 | 0 | 0 | Against |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 16,046 | 0 | 0 | Against |
| SEI | 0 | 14,652 | 0 | 0 | Against |
| ProShares | 0 | 13,143 | 0 | 0 | Against |
| TARGET PORTFOLIO TRUST | 12,900 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 11,658 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 10,973 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 9,396 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 0 | 8,432 | 0 | 0 | Against |
Fund voting reports, all 52 managers: 2,059,922 for, 6,566,402 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 2,038,763 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 1,060,002 | 0 | 0 | 0 | For |
| Versant Venture Management, LLC | 148,831 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 0 | 24,211 | 0 | 0 | Against |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 0 | 4,945 | 0 | 0 | Against |
| HOLDERNESS INVESTMENTS CO | 2,469 | 0 | 0 | 0 | For |
| SevenBridge Financial Group, LLC | 2,150 | 0 | 0 | 0 | For |
| Vident Advisory, LLC | 2,120 | 0 | 0 | 0 | For |
| Atlantic Union Bankshares Corp | 1,566 | 0 | 0 | 0 | For |
| Waverly Advisors, LLC | 1,532 | 0 | 0 | 0 | For |
| Bogart Wealth, LLC | 1,250 | 0 | 0 | 0 | For |
| Sound View Wealth Advisors Group, LLC | 1,214 | 0 | 0 | 0 | For |
| Formidable Asset Management, LLC | 1,190 | 0 | 0 | 0 | For |
| ZACKS INVESTMENT MANAGEMENT | 862 | 0 | 0 | 0 | For |
| DDD Partners, LLC | 819 | 0 | 0 | 0 | For |
| WIMMER ASSOCIATES 1, LLC | 650 | 0 | 0 | 0 | For |
| MERIDIAN INVESTMENT COUNSEL INC. | 575 | 0 | 0 | 0 | For |
| Journey Advisory Group, LLC | 500 | 0 | 0 | 0 | For |
| Naviter Wealth, LLC | 350 | 0 | 0 | 0 | For |
| CARY STREET PARTNERS FINANCIAL LLC | 340 | 0 | 0 | 0 | For |
| Summit Trail Advisors, LLC | 0 | 338 | 0 | 0 | Against |
| Legacy Capital Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
| Performance Wealth Partners, LLC | 300 | 0 | 0 | 0 | For |
| Rodgers Brothers Inc. | 0 | 300 | 0 | 0 | Against |
| Burns Matteson Capital Management, LLC | 288 | 0 | 0 | 0 | For |
Institutional-manager reports, all 48 managers: 3,267,824 for, 30,135 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report: Binding vote on maximum non-performance-related compensation for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.
The 59 asset managers below reported 18,971,235 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Vanguard | 284,481 | 0 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 136,013 | 0 | 0 | 0 | For |
| Lincoln Financial | 128,668 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 76,100 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
| ProShares | 13,143 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 10,973 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 9,396 | 0 | 0 | 0 | For |
| Calvert | 7,475 | 0 | 0 | 0 | For |
| Franklin Templeton | 6,651 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. All 59 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Re-election of the auditors.
CRISPR THERAPEUTICS AG’s own tally for this item (“12. Re-election of the Auditors”): 69,875,653 for, 462,910 against, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 73 asset managers below reported 19,654,021 for, 22,320 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 9,776,043 | 0 | 0 | 0 | For |
| Capital Group | 5,387,072 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,225,508 | 0 | 0 | 0 | For |
| BlackRock | 908,144 | 0 | 0 | 0 | For |
| Charles Schwab | 557,037 | 0 | 0 | 0 | For |
| Vanguard | 287,766 | 0 | 0 | 0 | For |
| State Street | 198,049 | 0 | 0 | 0 | For |
| Fidelity | 177,743 | 0 | 0 | 0 | For |
| ARK Venture Fund | 171,926 | 0 | 0 | 0 | For |
| Equitable | 136,013 | 0 | 0 | 0 | For |
| Lincoln Financial | 135,158 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 125,188 | 0 | 0 | 0 | For |
| Natixis | 76,100 | 0 | 0 | 0 | For |
| American Century | 59,438 | 0 | 0 | 0 | For |
| Clough Global Equity Fund | 41,270 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 40,875 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 37,600 | 0 | 0 | 0 | For |
| Northwestern Mutual | 33,247 | 0 | 0 | 0 | For |
| Guggenheim | 32,826 | 0 | 0 | 0 | For |
| Investment Managers Series Trust II | 31,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 0 | 22,300 | 0 | Abstain |
| Global X | 17,975 | 0 | 0 | 0 | For |
| John Hancock | 17,087 | 0 | 0 | 0 | For |
| JPMorgan | 16,747 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 16,046 | 0 | 0 | 0 | For |
Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of June 5, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 96,385,506 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARK ETF Trust | 10.14% |
| 2 | Capital Group | 5.59% |
| 3 | T. Rowe Price | 1.27% |
| 4 | BlackRock | 0.94% |
| 5 | Charles Schwab | 0.58% |
| 6 | Vanguard | 0.30% |
| 7 | State Street | 0.21% |
| 8 | Fidelity | 0.18% |
| 9 | ARK Venture Fund | 0.18% |
| 10 | Equitable | 0.14% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 6.26% |
| 2 | SR ONE CAPITAL MANAGEMENT, LP | 2.12% |
| 3 | T. Rowe Price | 2.00% |
| 4 | Amova Asset Management Co., Ltd. | 1.90% |
| 5 | BlackRock | 1.27% |
| 6 | NEA Management Company, LLC | 1.10% |
| 7 | State Street | 0.89% |
| 8 | Charles Schwab | 0.58% |
| 9 | ARK Investment Management LLC | 0.57% |
| 10 | Loomis Sayles | 0.57% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| ARK Investment Management LLC | 11,313,623 | 11.74% | Schedule 13G, filed April 30, 2026 |
| BlackRock | 7,680,073 | 7.97% | Form 13F, quarter ended March 31, 2026 |
| ORBIS INVESTMENT MANAGEMENT LTD | 5,433,344 | 5.64% | Schedule 13G, filed August 14, 2026 |
| Capital World Investors | 4,929,428 | 5.11% | Schedule 13G, filed May 14, 2026 |
| State Street | 3,982,500 | 4.13% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 2,377,164 | 2.47% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 2,268,394 | 2.35% | Form 13F, quarter ended March 31, 2026 |
| Simeon J. George, M.D. | 2,188,680 | 2.27% | Proxy statement (DEF 14A), table as of March 31, 2026 |
| FMR (Fidelity) | 1,954,694 | 2.03% | Form 13F, quarter ended March 31, 2026 |
| Samarth Kulkarni, Ph.D. | 1,603,279 | 1.66% | Proxy statement (DEF 14A), table as of March 31, 2026 |
Percentages above are of 96,385,506 shares outstanding, as reported by CRISPR THERAPEUTICS AG on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At CRISPR THERAPEUTICS AG's shareholder meeting held June 4, 2026, in the 2025-2026 proxy season, 513 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 6,597 separate fund positions. Their filings are grouped here into 33 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — NON-BINDING ADVISORY VOTE ON THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS… — CRISPR THERAPEUTICS AG's filing reports the proposal as approved, with 69% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CRISPR THERAPEUTICS AG's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CRISPR THERAPEUTICS AG’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
CRISPR THERAPEUTICS AG proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “CRISPR THERAPEUTICS (CRSP) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/crispr-therapeutics-ag/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.